Today, FDA approved the first COVID-19 vaccine for the prevention of # COVID19 disease in individuals 16 years of age and older. https://t.co/iOqsxXV1fj – US FDA (@US_FDA) August 23, 2021
From now on the immunization of the pharmaceutical will be called Comirnaty . It is the only serum of its kind that receives a total green light in the United States, which could lead to it being marketed directly to the consumer.
- To learn more: Pfizer’s Covid-19 Vaccine Receives Full FDA Approval and Will Now Be Sold to the Public
As reported by Forbes , Janet Woodcock, the acting commissioner of this regulator, pointed out that with this final authorization, the US population “can be sure that this vaccine meets the FDA’s gold standards in terms of safety, efficacy and quality. manufacturing ”.
It is not the first vaccine to change its name. In March this year, the Anglo -Swedish pharmaceutical company AstraZeneca announced that the vaccine against COVID-19 that it developed in conjunction with the British University of Oxford was renamed Vaxzevria .
- You may be interested: What Covid-19 vaccines do they accept to travel to Europe, the United States and the rest of the world